Literature DB >> 1367911

Enhancing effect of mouse peritoneal exudate cells and their products on antibody productivity of hybridoma cells: application of in vivo factors to in vitro culture.

T Mikami1, F Makishima, E Suzuki.   

Abstract

Mouse peritoneal exudate cells induced by casein enhanced in vitro antibody production rate per cell of a hybridoma in co-culture. Culture supernatant of the exudate cells also enhanced three-fold the antibody productivity when added to cultures of a hybridoma at 10% (v/v). Hence the enhancement of antibody productivity by the exudate cells seemed to be caused by soluble enhancing factors secreted by the exudate cells. The exudate cells maximally secreted the enhancing factors when harvested from mice on day 4 of the induction period following the injection of casein. A semi-continuous culture of the hybridoma demonstrated the applicability of the culture supernatant to enhance antibody production by producing a two-fold increase over the control for seven days when supplemented with the supernatant at 5%. Significant amounts of interleukin-6 were detected in culture supernatant of the exudate cells. Interleukin-6 obtained from other sources enhanced the antibody productivity two-fold when added to the hybridoma culture at the concentration of 5 unit/ml. Interleukin-6, therefore, is expected to be one of the principal antibody enhancing factors secreted by the exudate cells. Other interleukins examined, that is, interleukin-1 to -5 did not enhance the antibody productivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367911     DOI: 10.1007/bf00350915

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  9 in total

1.  Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured model.

Authors:  E Suzuki; D F Ollis
Journal:  Biotechnol Prog       Date:  1990 May-Jun

2.  Electron microscopy of hybridoma cells with special regard to monoclonal antibody production.

Authors:  M al-Rubeai; D Mills; A N Emery
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

3.  A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: effect of nutrient concentration, dilution rate, and pH.

Authors:  W M Miller; H W Blanch; C R Wilke
Journal:  Biotechnol Bioeng       Date:  1988-10-05       Impact factor: 4.530

4.  Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action.

Authors:  P J Conlon; C S Henney; S Gillis
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

5.  Physicochemical characterization of a PMN-derived soluble fraction that enhances lymphocyte DNA synthesis.

Authors:  S Nakamura; F Goto; K Goto; M Yoshinaga
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

Review 6.  Antibody production by hybridomas.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

8.  Batch production and secretion kinetics of hybridomas: pulse-chase experiments.

Authors:  O W Merten; H Keller; L Cabanié; M Leno; M Hardefelt
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

9.  Production of monoclonal antibodies in culture.

Authors:  S Reuveny; D Velez; F Riske; J D MacMillan; L Miller
Journal:  Dev Biol Stand       Date:  1985
  9 in total
  1 in total

1.  Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.

Authors:  Christiane Stuhlmann-Laeisz; Sigrid Lang; Athena Chalaris; Paliga Krzysztof; Sudarman Enge; Jutta Eichler; Ursula Klingmüller; Michael Samuel; Matthias Ernst; Stefan Rose-John; Jürgen Scheller
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.